ArticlePharmacoEconomics2023

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States.

Mickaël Hiligsmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.